Spero Therapeutics (SPRO)
(Delayed Data from NSDQ)
$1.43 USD
+0.01 (0.70%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.44 +0.01 (0.70%) 7:18 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.07 | 0.00% |
Earnings Summary
For their last quarter, Spero Therapeutics (SPRO) reported earnings of $0.96 per share, beating the Zacks Consensus Estimate of $-0.18 per share. This reflects a positive earnings surprise of 633.33%. Look out for SPRO's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year increase of 72%.
Earnings History
Price & Consensus
Zacks News for SPRO
Will Zimmer Biomet (ZBH) Beat Estimates This Earnings Season?
SPRO: What are Zacks experts saying now?
Zacks Private Portfolio Services